SFM
VTAE

Sphera Funds Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Sphera Funds Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-120,000
Closed -$2.17M – 138
2015
Q4 		$2.17M Buy
+120,000
New +$1.65M 0.32% 80

Other funds holding VTAE

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's VTAE Position: Q1 2016 in Review

Sphera Funds Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q1 2016, closing a stake of 120,000 shares — an estimated $2.17M sold.

Sphera Funds Management first reported a position in VTAE in Q4 2015 and held it in 1 quarter. The position peaked at $2.17M in Q4 2015. 78 funds tracked by Wall St. Rank hold VTAE as of Q1 2016.

  • Sphera Funds Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 120,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q1 2016, an estimated $2.17M.
  • Sphera Funds Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Sphera Funds Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.17M in Q4 2015.
  • 78 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.